⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL8378977 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL4864416 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL3396204 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL5046068 | 0.90 | — | — | |
| Cysteine SCHEMBL8501902 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL23903319 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL1072972 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL16194528 | 0.90 | — | — | |
| Cysteine SCHEMBL5307589 | 0.90 | PTGS1 (0.55) | — | |
| Cysteine SCHEMBL17473902 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100272814-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | PHARMALUNDENSIS AB (SE) | 2010-10-28 | — | — | US | claimed |
| EP-2234626-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | Pharmalundensis AB (SE) | 2010-10-06 | — | — | EP | claimed |
| WO-2009078782-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | PHARMALUNDENSIS AB (SE) | 2009-06-25 | — | — | WO | claimed |
| US-20240052418-A1 | METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-02-15 | — | — | US | disclosed |
| US-11814681-B2 | Method for predicting a subjects response to SLC modulator therapy | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2023-11-14 | — | — | US | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210254158-A1 | METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY | RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. | 2021-08-19 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20100272814-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | PHARMALUNDENSIS AB (SE) | 2010-10-28 | — | — | US | disclosed |
| EP-2234626-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | Pharmalundensis AB (SE) | 2010-10-06 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2009078782-A1 | METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION | PHARMALUNDENSIS AB (SE) | 2009-06-25 | — | — | WO | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |